AZN

EU signs contract with AstraZeneca on supply of potential COVID-19 vaccine

Credit: REUTERS/BRENDAN MCDERMID

The European Commission said on Thursday it had signed a contract on behalf of EU states with British drugmaker AstraZeneca for the supply of at least 300 million doses of its COVID-19 vaccine candidate.

BRUSSELS, Aug 27 (Reuters) - The European Commission said on Thursday it had signed a contract on behalf of EU states with British drugmaker AstraZeneca AZN.L for the supply of at least 300 million doses of its COVID-19 vaccine candidate.

The move follows an advance purchase agreement signed by Brussels with AstraZeneca earlier in August.

It is the first contract signed by the EU with a maker of potential COVID-19 vaccines. The contract envisages an option to purchase 100 million additional doses to be distributed on a population-based pro-rata basis among the 27 EU states.

(Reporting by Francesco Guarascio @fraguarascio; Editing by Hugh Lawson)

((Francesco.Guarascio@thomsonreuters.com; +32 2 287 68 17;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More